CCO Official Conference Coverage: Clinical Impact of New HIV Data From AIDS 2022

Download All
July 29-August 2, 2022; Montreal, Quebec
Engage in this scientific analysis of data presented at AIDS 2022, with rapid postconference webinars by expert faculty and Capsule Summaries on key HIV prevention, treatment studies,and new and investigational ART regimens. Watch the on-demand webinars, download the slides, and gain global perspectives with companion ClinicalThought commentaries.
person default
Chien-Ching Hung, MD, PhD
Daniel R. Kuritzkes, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Jürgen K. Rockstroh, MD
Babafemi Taiwo, MBBS
David A. Wohl, MD

Highlights

Dr Sharon R. Lewin, incoming President of the International AIDS Society, provides an overview of the most clinically exciting papers to be presented at the upcoming conference.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: July 13, 2022

Read my take on the most practice-changing clinical presentations from the recent AIDS 2022 conference in Montreal.

Daniel R. Kuritzkes, MD Released: August 23, 2022

Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, and comorbidities.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS David A. Wohl, MD Released: August 17, 2022

Listen to expert insights from Chloe Orkin, MBChB, FRCP, MD, on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral and long-acting therapies, cure, and COVID-19 in people with HIV.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: October 4, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

David A. Wohl, MD Released: August 19, 2022

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: September 20, 2022

Global Perspectives

Read my take on an interesting clinical presentation from the recent AIDS 2022 Conference in Montreal evaluating TDF vs TAF in HIV/HBV coinfection.

Jürgen K. Rockstroh, MD Released: August 19, 2022

Here’s my perspective on how the DoxyPEP and ALLIANCE studies from AIDS 2022 may impact treatment of people with HIV in the Asia-Pacific region.

person default Chien-Ching Hung, MD, PhD Released: September 16, 2022

 

 

 

Conference organizers are using social media to communicate with delegates attending the meeting.

Social Media
Join the #AIDS2022 conversation

  

Facebook, Twitter, Instagram, LinkedIn

For more information about these resources and IAS 2022, go to www.aids2022.org.

NAM is the official provider of online scientific news reporting for the conference.

To view the coverage and to sign up for the bulletins, go to https://www.aidsmap.com/conferences/aids-2022.

Conference News – Reported by NAM

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings